Škof E, Krajc M. Lynparzatm (olaparib): new medicine for targeted therapy of ovarian cancer. Onkologija [Internet]. 2016 Jun. 15 [cited 2026 May 7];20(1):12-4. Available from: https://www.revijaonkologija.si/Onkologija/article/view/60